| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvate Kinase | 29 | 2022 | 190 | 4.870 |
Why?
|
| Glycolysis | 35 | 2024 | 838 | 4.630 |
Why?
|
| Cell Proliferation | 58 | 2025 | 10486 | 3.550 |
Why?
|
| Neoplasms | 63 | 2024 | 22389 | 3.230 |
Why?
|
| Glucose | 42 | 2024 | 4352 | 3.090 |
Why?
|
| Nucleotides | 10 | 2024 | 455 | 2.490 |
Why?
|
| Serine | 13 | 2020 | 831 | 2.470 |
Why?
|
| Metabolic Networks and Pathways | 18 | 2019 | 800 | 2.430 |
Why?
|
| Thyroid Hormones | 7 | 2021 | 407 | 2.400 |
Why?
|
| Tumor Microenvironment | 21 | 2024 | 3952 | 2.320 |
Why?
|
| Energy Metabolism | 17 | 2023 | 2905 | 2.050 |
Why?
|
| Phosphoglycerate Dehydrogenase | 8 | 2020 | 38 | 1.850 |
Why?
|
| Mitochondria | 33 | 2025 | 3682 | 1.770 |
Why?
|
| NAD | 8 | 2022 | 618 | 1.750 |
Why?
|
| Pancreatic Neoplasms | 20 | 2024 | 5443 | 1.750 |
Why?
|
| Glutamine | 18 | 2021 | 578 | 1.740 |
Why?
|
| Aspartic Acid | 5 | 2023 | 577 | 1.690 |
Why?
|
| Carcinoma, Pancreatic Ductal | 12 | 2022 | 1756 | 1.640 |
Why?
|
| Amino Acids, Branched-Chain | 4 | 2020 | 268 | 1.470 |
Why?
|
| Adenosine Triphosphate | 16 | 2023 | 2003 | 1.430 |
Why?
|
| DNA Replication | 4 | 2024 | 1428 | 1.210 |
Why?
|
| Cell Line, Tumor | 55 | 2025 | 17173 | 1.200 |
Why?
|
| Carrier Proteins | 8 | 2021 | 4939 | 1.190 |
Why?
|
| Isocitrate Dehydrogenase | 13 | 2018 | 958 | 1.150 |
Why?
|
| Neoplasm Transplantation | 10 | 2021 | 2018 | 1.060 |
Why?
|
| Animals | 133 | 2024 | 169335 | 1.040 |
Why?
|
| Neoplasm Metastasis | 6 | 2024 | 4926 | 1.010 |
Why?
|
| Pancreatic Stellate Cells | 2 | 2022 | 28 | 0.950 |
Why?
|
| Membrane Proteins | 10 | 2021 | 7885 | 0.930 |
Why?
|
| Cell Physiological Phenomena | 2 | 2018 | 152 | 0.920 |
Why?
|
| Amino Acids | 7 | 2024 | 1716 | 0.900 |
Why?
|
| Citric Acid Cycle | 11 | 2023 | 234 | 0.870 |
Why?
|
| Mice | 90 | 2024 | 82072 | 0.870 |
Why?
|
| Pinocytosis | 4 | 2020 | 63 | 0.870 |
Why?
|
| Metabolomics | 9 | 2024 | 1675 | 0.830 |
Why?
|
| Signal Transduction | 28 | 2024 | 23653 | 0.830 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 28 | 0.790 |
Why?
|
| Oxidation-Reduction | 14 | 2022 | 2226 | 0.760 |
Why?
|
| Glycine Hydroxymethyltransferase | 4 | 2025 | 34 | 0.750 |
Why?
|
| Fatty Acids | 6 | 2023 | 1812 | 0.750 |
Why?
|
| Electron Transport Complex I | 2 | 2023 | 153 | 0.700 |
Why?
|
| Carbon | 6 | 2017 | 672 | 0.690 |
Why?
|
| Transaminases | 3 | 2018 | 199 | 0.680 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2017 | 2848 | 0.670 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 11 | 2003 | 1408 | 0.660 |
Why?
|
| Enzyme Activators | 5 | 2015 | 56 | 0.650 |
Why?
|
| Oxidative Phosphorylation | 11 | 2017 | 501 | 0.640 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2019 | 79 | 0.640 |
Why?
|
| Cell Respiration | 5 | 2021 | 201 | 0.640 |
Why?
|
| High-Throughput Screening Assays | 2 | 2023 | 942 | 0.630 |
Why?
|
| Humans | 180 | 2025 | 768970 | 0.630 |
Why?
|
| Mutation | 28 | 2023 | 30266 | 0.630 |
Why?
|
| Glycine | 5 | 2022 | 672 | 0.630 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2021 | 263 | 0.620 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 76 | 0.620 |
Why?
|
| Glutaminase | 2 | 2017 | 32 | 0.610 |
Why?
|
| Brain Neoplasms | 11 | 2021 | 9213 | 0.600 |
Why?
|
| Cell Cycle Proteins | 3 | 2024 | 3450 | 0.590 |
Why?
|
| Acetyl Coenzyme A | 2 | 2017 | 74 | 0.570 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2018 | 84 | 0.570 |
Why?
|
| Enzymes | 2 | 2016 | 254 | 0.570 |
Why?
|
| Melanins | 1 | 2019 | 292 | 0.560 |
Why?
|
| Cystine | 1 | 2017 | 96 | 0.560 |
Why?
|
| Cell Culture Techniques | 3 | 2023 | 1667 | 0.550 |
Why?
|
| NADP | 4 | 2021 | 230 | 0.550 |
Why?
|
| Diet, Protein-Restricted | 1 | 2017 | 73 | 0.550 |
Why?
|
| Cells | 4 | 2013 | 166 | 0.540 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2023 | 1769 | 0.530 |
Why?
|
| Oncogenes | 3 | 2014 | 1236 | 0.520 |
Why?
|
| Lung Neoplasms | 11 | 2024 | 13594 | 0.520 |
Why?
|
| Cell Cycle | 8 | 2023 | 2937 | 0.510 |
Why?
|
| Drug Resistance, Neoplasm | 9 | 2021 | 5342 | 0.510 |
Why?
|
| Prostatic Neoplasms | 12 | 2024 | 11230 | 0.510 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 2013 | 64 | 0.510 |
Why?
|
| Glioma | 7 | 2018 | 3532 | 0.500 |
Why?
|
| Glutamic Acid | 4 | 2021 | 1191 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 24 | 2024 | 22379 | 0.500 |
Why?
|
| Lymphangiogenesis | 1 | 2017 | 171 | 0.500 |
Why?
|
| Metabolism | 2 | 2021 | 193 | 0.500 |
Why?
|
| Pyruvic Acid | 6 | 2016 | 205 | 0.500 |
Why?
|
| Metabolome | 3 | 2023 | 1009 | 0.490 |
Why?
|
| Protein Isoforms | 4 | 2019 | 1714 | 0.490 |
Why?
|
| Glutarates | 6 | 2018 | 243 | 0.490 |
Why?
|
| Isoenzymes | 9 | 2016 | 1687 | 0.490 |
Why?
|
| Lysosomes | 3 | 2018 | 940 | 0.480 |
Why?
|
| Cell Survival | 16 | 2022 | 5793 | 0.480 |
Why?
|
| Homeostasis | 9 | 2018 | 3347 | 0.480 |
Why?
|
| Food | 2 | 2021 | 768 | 0.470 |
Why?
|
| Lipid Metabolism | 3 | 2021 | 1904 | 0.470 |
Why?
|
| Starvation | 1 | 2015 | 141 | 0.460 |
Why?
|
| Metformin | 3 | 2018 | 909 | 0.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2024 | 8664 | 0.450 |
Why?
|
| Mice, Nude | 10 | 2018 | 3631 | 0.440 |
Why?
|
| Enzyme Inhibitors | 7 | 2021 | 3726 | 0.440 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 899 | 0.440 |
Why?
|
| Serum Albumin | 1 | 2016 | 677 | 0.430 |
Why?
|
| Circadian Clocks | 1 | 2015 | 168 | 0.430 |
Why?
|
| Carbohydrate Metabolism | 3 | 2023 | 262 | 0.420 |
Why?
|
| Cell Line | 24 | 2023 | 15604 | 0.420 |
Why?
|
| Phosphofructokinase-1, Liver Type | 1 | 2012 | 1 | 0.420 |
Why?
|
| Cell Division | 7 | 2023 | 4478 | 0.420 |
Why?
|
| S Phase | 3 | 2024 | 424 | 0.400 |
Why?
|
| Interleukin-3 | 5 | 2016 | 425 | 0.400 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 704 | 0.400 |
Why?
|
| Models, Biological | 11 | 2021 | 9499 | 0.390 |
Why?
|
| Apoptosis | 17 | 2023 | 9527 | 0.390 |
Why?
|
| Drosophila melanogaster | 1 | 2021 | 1726 | 0.390 |
Why?
|
| Phosphoglycerate Mutase | 2 | 2010 | 16 | 0.390 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2023 | 5434 | 0.390 |
Why?
|
| Biopolymers | 1 | 2012 | 183 | 0.390 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2016 | 506 | 0.390 |
Why?
|
| Immune System | 1 | 2017 | 800 | 0.380 |
Why?
|
| Disease Models, Animal | 12 | 2021 | 18354 | 0.380 |
Why?
|
| Aerobiosis | 4 | 2020 | 100 | 0.380 |
Why?
|
| Gene Expression | 6 | 2021 | 7603 | 0.370 |
Why?
|
| Macrophages | 2 | 2024 | 5801 | 0.370 |
Why?
|
| Antineoplastic Agents | 10 | 2021 | 13698 | 0.360 |
Why?
|
| Adipose Tissue | 3 | 2023 | 3335 | 0.360 |
Why?
|
| Adenocarcinoma | 5 | 2022 | 6401 | 0.350 |
Why?
|
| Glucose Transporter Type 1 | 5 | 2021 | 186 | 0.350 |
Why?
|
| Burkitt Lymphoma | 2 | 2023 | 338 | 0.350 |
Why?
|
| Gene Deletion | 3 | 2015 | 2674 | 0.350 |
Why?
|
| bcl-X Protein | 11 | 2016 | 412 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2024 | 3200 | 0.340 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2211 | 0.340 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2893 | 0.330 |
Why?
|
| Immunologic Memory | 1 | 2016 | 1378 | 0.330 |
Why?
|
| Blood Glucose | 2 | 2021 | 6435 | 0.320 |
Why?
|
| Extracellular Fluid | 2 | 2021 | 165 | 0.320 |
Why?
|
| Small Molecule Libraries | 4 | 2023 | 742 | 0.320 |
Why?
|
| L-Lactate Dehydrogenase | 4 | 2023 | 412 | 0.320 |
Why?
|
| Protein Kinases | 2 | 2015 | 1611 | 0.320 |
Why?
|
| Gene Knockdown Techniques | 7 | 2022 | 1608 | 0.300 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2021 | 1169 | 0.300 |
Why?
|
| Ketoglutaric Acids | 5 | 2016 | 76 | 0.300 |
Why?
|
| Mice, 129 Strain | 3 | 2019 | 369 | 0.300 |
Why?
|
| Organ Specificity | 4 | 2023 | 1970 | 0.300 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2021 | 3621 | 0.300 |
Why?
|
| Fibroblasts | 4 | 2021 | 4179 | 0.300 |
Why?
|
| Mice, Transgenic | 11 | 2019 | 9565 | 0.290 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2021 | 4651 | 0.290 |
Why?
|
| Kidney Neoplasms | 2 | 2024 | 4300 | 0.290 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 21188 | 0.290 |
Why?
|
| Protein Biosynthesis | 6 | 2024 | 2094 | 0.290 |
Why?
|
| Circadian Rhythm | 2 | 2016 | 2593 | 0.280 |
Why?
|
| Heme | 2 | 2020 | 316 | 0.280 |
Why?
|
| Molecular Targeted Therapy | 7 | 2022 | 2830 | 0.280 |
Why?
|
| Disease Progression | 10 | 2024 | 13674 | 0.280 |
Why?
|
| Adaptation, Physiological | 2 | 2016 | 1313 | 0.280 |
Why?
|
| Porins | 4 | 2001 | 78 | 0.280 |
Why?
|
| Phenotype | 6 | 2019 | 16731 | 0.270 |
Why?
|
| Body Composition | 3 | 2023 | 2462 | 0.270 |
Why?
|
| Obesity | 5 | 2024 | 13091 | 0.270 |
Why?
|
| Genes, ras | 2 | 2021 | 665 | 0.270 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11684 | 0.270 |
Why?
|
| Adenosine Diphosphate | 4 | 2001 | 422 | 0.270 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3608 | 0.270 |
Why?
|
| Intracellular Membranes | 5 | 2001 | 388 | 0.260 |
Why?
|
| HeLa Cells | 5 | 2020 | 3076 | 0.260 |
Why?
|
| Diet | 3 | 2024 | 8088 | 0.260 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 4363 | 0.250 |
Why?
|
| DNA Damage | 6 | 2024 | 2472 | 0.250 |
Why?
|
| Caspases | 3 | 2023 | 881 | 0.250 |
Why?
|
| Tumor Cells, Cultured | 9 | 2021 | 6131 | 0.240 |
Why?
|
| Phosphoenolpyruvate | 3 | 2015 | 16 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1064 | 0.240 |
Why?
|
| Pyridoxal Phosphate | 1 | 2025 | 123 | 0.240 |
Why?
|
| Mammals | 3 | 2023 | 1136 | 0.240 |
Why?
|
| Biological Transport | 5 | 2024 | 2085 | 0.240 |
Why?
|
| Methotrexate | 2 | 2021 | 1723 | 0.240 |
Why?
|
| Membrane Transport Proteins | 2 | 2020 | 1038 | 0.230 |
Why?
|
| Folic Acid | 2 | 2021 | 1338 | 0.230 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2024 | 35 | 0.230 |
Why?
|
| HEK293 Cells | 5 | 2020 | 4290 | 0.230 |
Why?
|
| Protein Multimerization | 2 | 2019 | 968 | 0.230 |
Why?
|
| Polyamines | 1 | 2024 | 133 | 0.220 |
Why?
|
| Electron Transport Complex II | 1 | 2023 | 53 | 0.220 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2023 | 111 | 0.220 |
Why?
|
| RNA, Ribosomal | 1 | 2024 | 227 | 0.220 |
Why?
|
| Mice, Inbred NOD | 4 | 2021 | 1839 | 0.220 |
Why?
|
| Kupffer Cells | 1 | 2024 | 143 | 0.220 |
Why?
|
| Deceleration | 1 | 2023 | 10 | 0.220 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 2336 | 0.220 |
Why?
|
| Cytosol | 2 | 2018 | 886 | 0.210 |
Why?
|
| Peroxiredoxins | 1 | 2023 | 51 | 0.210 |
Why?
|
| Kinetics | 5 | 2019 | 6332 | 0.210 |
Why?
|
| Electrons | 3 | 2023 | 264 | 0.210 |
Why?
|
| Uracil | 1 | 2024 | 210 | 0.210 |
Why?
|
| Pyruvaldehyde | 2 | 2019 | 16 | 0.200 |
Why?
|
| Amino Acid Transport Systems | 2 | 2024 | 34 | 0.200 |
Why?
|
| Leucine | 2 | 2023 | 548 | 0.200 |
Why?
|
| Research Design | 1 | 2018 | 6214 | 0.200 |
Why?
|
| Ketone Bodies | 1 | 2022 | 76 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2024 | 1616 | 0.200 |
Why?
|
| Genes, Fungal | 2 | 2002 | 440 | 0.190 |
Why?
|
| Histone Chaperones | 1 | 2022 | 82 | 0.190 |
Why?
|
| Alternative Splicing | 4 | 2011 | 1105 | 0.190 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 230 | 0.190 |
Why?
|
| Glutathione | 3 | 2019 | 589 | 0.190 |
Why?
|
| Tetrahydrofolates | 1 | 2021 | 58 | 0.190 |
Why?
|
| Leukemia | 2 | 2023 | 1520 | 0.190 |
Why?
|
| Proteins | 7 | 2016 | 6011 | 0.190 |
Why?
|
| Cell Hypoxia | 5 | 2015 | 662 | 0.190 |
Why?
|
| Mitochondrial Membranes | 2 | 2020 | 185 | 0.190 |
Why?
|
| Retina | 1 | 2012 | 2661 | 0.190 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2021 | 84 | 0.190 |
Why?
|
| Gene Knockout Techniques | 4 | 2023 | 808 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2021 | 1120 | 0.190 |
Why?
|
| Nitroquinolines | 1 | 2020 | 4 | 0.190 |
Why?
|
| Fibrillar Collagens | 1 | 2021 | 42 | 0.190 |
Why?
|
| Oxygen Consumption | 6 | 2015 | 1883 | 0.190 |
Why?
|
| Receptors, OX40 | 1 | 2021 | 46 | 0.180 |
Why?
|
| Principal Component Analysis | 1 | 2024 | 948 | 0.180 |
Why?
|
| Aspartate Aminotransferases | 1 | 2022 | 414 | 0.180 |
Why?
|
| Embryo, Mammalian | 3 | 2016 | 1676 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2024 | 573 | 0.180 |
Why?
|
| Arginase | 1 | 2021 | 81 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 3626 | 0.180 |
Why?
|
| Reactive Oxygen Species | 6 | 2023 | 2149 | 0.180 |
Why?
|
| Male | 37 | 2024 | 365203 | 0.180 |
Why?
|
| Lactoylglutathione Lyase | 1 | 2019 | 7 | 0.170 |
Why?
|
| Isoleucine | 1 | 2020 | 112 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2024 | 715 | 0.170 |
Why?
|
| HCT116 Cells | 2 | 2018 | 405 | 0.170 |
Why?
|
| Fluorouracil | 1 | 2024 | 1655 | 0.160 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 4 | 2025 | 170 | 0.160 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2021 | 647 | 0.160 |
Why?
|
| Caloric Restriction | 1 | 2021 | 301 | 0.160 |
Why?
|
| Pregnancy Proteins | 2 | 2018 | 222 | 0.160 |
Why?
|
| Lactic Acid | 6 | 2021 | 1140 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2018 | 304 | 0.160 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2018 | 30 | 0.150 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 242 | 0.150 |
Why?
|
| Protein Structure, Quaternary | 1 | 2019 | 426 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2020 | 379 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2021 | 542 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 173 | 0.150 |
Why?
|
| Epidermal Growth Factor | 1 | 2021 | 697 | 0.150 |
Why?
|
| Mutagenesis | 3 | 2021 | 1229 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2024 | 1218 | 0.150 |
Why?
|
| Antioxidants | 4 | 2017 | 1673 | 0.150 |
Why?
|
| Oxygen | 5 | 2017 | 4272 | 0.150 |
Why?
|
| Fasting | 1 | 2024 | 1610 | 0.150 |
Why?
|
| Exons | 3 | 2013 | 2395 | 0.150 |
Why?
|
| Argininosuccinate Synthase | 1 | 2017 | 16 | 0.150 |
Why?
|
| Chromatin | 2 | 2022 | 2981 | 0.150 |
Why?
|
| Proline Oxidase | 1 | 2017 | 4 | 0.150 |
Why?
|
| Amino Acids, Essential | 1 | 2017 | 26 | 0.150 |
Why?
|
| Colon | 2 | 2024 | 1803 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 627 | 0.150 |
Why?
|
| Nutritional Requirements | 1 | 2019 | 279 | 0.140 |
Why?
|
| Immunotherapy | 3 | 2024 | 4756 | 0.140 |
Why?
|
| Voltage-Dependent Anion Channels | 4 | 2001 | 15 | 0.140 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 384 | 0.140 |
Why?
|
| Cell Death | 3 | 2023 | 1682 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 40 | 0.140 |
Why?
|
| Allosteric Regulation | 2 | 2023 | 424 | 0.140 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 573 | 0.140 |
Why?
|
| Acetates | 2 | 2016 | 317 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2022 | 1143 | 0.140 |
Why?
|
| DNA Repair | 2 | 2024 | 2054 | 0.140 |
Why?
|
| Hair Follicle | 1 | 2019 | 219 | 0.140 |
Why?
|
| Doxycycline | 1 | 2019 | 349 | 0.140 |
Why?
|
| Antiporters | 1 | 2018 | 276 | 0.140 |
Why?
|
| Antimetabolites | 1 | 2017 | 129 | 0.140 |
Why?
|
| T-Lymphocytes | 7 | 2023 | 10276 | 0.140 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9549 | 0.140 |
Why?
|
| Chromatography, Gas | 1 | 2016 | 150 | 0.140 |
Why?
|
| Female | 30 | 2024 | 397515 | 0.140 |
Why?
|
| Receptors, Virus | 1 | 2020 | 652 | 0.140 |
Why?
|
| Nitrogen Isotopes | 1 | 2016 | 83 | 0.140 |
Why?
|
| Albumins | 2 | 2016 | 577 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6512 | 0.140 |
Why?
|
| Asparaginase | 1 | 2018 | 240 | 0.140 |
Why?
|
| Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 10 | 0.140 |
Why?
|
| Guinea Pigs | 1 | 2018 | 1309 | 0.130 |
Why?
|
| Tumor Burden | 3 | 2018 | 1913 | 0.130 |
Why?
|
| Prostate | 2 | 2022 | 1781 | 0.130 |
Why?
|
| Growth and Development | 1 | 2016 | 46 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2022 | 1337 | 0.130 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
| Plasmapheresis | 1 | 2016 | 206 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2022 | 2884 | 0.130 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 40 | 0.130 |
Why?
|
| Thermogenesis | 1 | 2020 | 494 | 0.130 |
Why?
|
| Phosphorylation | 4 | 2015 | 8317 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2016 | 998 | 0.130 |
Why?
|
| Fructosediphosphates | 3 | 2009 | 24 | 0.130 |
Why?
|
| Melanocytes | 1 | 2019 | 509 | 0.130 |
Why?
|
| Cells, Cultured | 8 | 2016 | 19023 | 0.130 |
Why?
|
| Stem Cells | 4 | 2024 | 3539 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2016 | 2592 | 0.130 |
Why?
|
| Ion Channels | 2 | 1999 | 1043 | 0.130 |
Why?
|
| Cytochrome c Group | 3 | 2001 | 123 | 0.130 |
Why?
|
| Proline | 1 | 2017 | 455 | 0.130 |
Why?
|
| Biosynthetic Pathways | 1 | 2016 | 138 | 0.130 |
Why?
|
| Hormones | 1 | 2019 | 870 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 89 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 2001 | 0.120 |
Why?
|
| Collagen | 2 | 2017 | 2646 | 0.120 |
Why?
|
| Glyceric Acids | 2 | 2014 | 17 | 0.120 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2017 | 292 | 0.120 |
Why?
|
| Nitrogen | 1 | 2016 | 345 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2024 | 2576 | 0.120 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 266 | 0.120 |
Why?
|
| Hemolysin Proteins | 1 | 2015 | 113 | 0.120 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 505 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 565 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2019 | 888 | 0.120 |
Why?
|
| Liver | 4 | 2024 | 7578 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2018 | 3592 | 0.120 |
Why?
|
| Butyrates | 1 | 2015 | 167 | 0.120 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 560 | 0.120 |
Why?
|
| Lung | 3 | 2019 | 10099 | 0.120 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 454 | 0.120 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 1750 | 0.120 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5906 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1794 | 0.120 |
Why?
|
| Phosphofructokinase-2 | 1 | 2014 | 33 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2017 | 5033 | 0.110 |
Why?
|
| Mice, Knockout | 7 | 2021 | 14484 | 0.110 |
Why?
|
| Epigenomics | 1 | 2020 | 961 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 3782 | 0.110 |
Why?
|
| Culture Media | 1 | 2015 | 898 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2021 | 1282 | 0.110 |
Why?
|
| Microfluidics | 1 | 2019 | 674 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 2 | 2011 | 126 | 0.110 |
Why?
|
| Substrate Specificity | 2 | 2015 | 1751 | 0.110 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2013 | 69 | 0.110 |
Why?
|
| Multiprotein Complexes | 2 | 2017 | 1111 | 0.110 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6982 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2002 | 2682 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2010 | 2986 | 0.100 |
Why?
|
| Research | 1 | 2021 | 1981 | 0.100 |
Why?
|
| Histidine | 2 | 2010 | 302 | 0.100 |
Why?
|
| ras Proteins | 2 | 2021 | 1058 | 0.100 |
Why?
|
| Podocytes | 1 | 2017 | 403 | 0.100 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 658 | 0.100 |
Why?
|
| Embryonic Induction | 1 | 2013 | 152 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 2063 | 0.100 |
Why?
|
| Iron | 1 | 2021 | 1814 | 0.100 |
Why?
|
| Citric Acid | 1 | 2013 | 124 | 0.100 |
Why?
|
| Lipids | 3 | 2022 | 3345 | 0.100 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 823 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 1682 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1019 | 0.100 |
Why?
|
| Cerebellar Neoplasms | 1 | 2017 | 591 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2024 | 3205 | 0.100 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 737 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 183 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 957 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2013 | 164 | 0.100 |
Why?
|
| Lymphocyte Activation | 3 | 2017 | 5505 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2017 | 683 | 0.100 |
Why?
|
| Cattle | 1 | 2017 | 3819 | 0.100 |
Why?
|
| Membrane Potentials | 3 | 2000 | 1090 | 0.100 |
Why?
|
| Myeloproliferative Disorders | 1 | 2018 | 616 | 0.090 |
Why?
|
| Mutant Proteins | 2 | 2011 | 488 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 11932 | 0.090 |
Why?
|
| Hexosamines | 1 | 2010 | 38 | 0.090 |
Why?
|
| Medical Oncology | 2 | 2021 | 2350 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2016 | 724 | 0.090 |
Why?
|
| Syndrome | 1 | 2017 | 3274 | 0.090 |
Why?
|
| Models, Molecular | 5 | 2013 | 5404 | 0.090 |
Why?
|
| Drug Discovery | 2 | 2022 | 1068 | 0.090 |
Why?
|
| Kidney | 2 | 2024 | 7058 | 0.090 |
Why?
|
| Neurogenesis | 1 | 2017 | 865 | 0.090 |
Why?
|
| Lactates | 1 | 2011 | 401 | 0.090 |
Why?
|
| Colonic Neoplasms | 2 | 2013 | 2543 | 0.090 |
Why?
|
| Lactate Dehydrogenases | 1 | 2010 | 26 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 128 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2010 | 30 | 0.090 |
Why?
|
| Melanoma | 3 | 2023 | 5709 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 973 | 0.090 |
Why?
|
| Phosphocreatine | 2 | 2001 | 261 | 0.080 |
Why?
|
| Lipogenesis | 1 | 2011 | 216 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 2013 | 17629 | 0.080 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 895 | 0.080 |
Why?
|
| Cerebellum | 1 | 2017 | 1522 | 0.080 |
Why?
|
| Ischemia | 2 | 2016 | 1900 | 0.080 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 122 | 0.080 |
Why?
|
| Dinosaurs | 1 | 2009 | 12 | 0.080 |
Why?
|
| Mass Spectrometry | 4 | 2023 | 2204 | 0.080 |
Why?
|
| Bacterial Toxins | 1 | 2015 | 922 | 0.080 |
Why?
|
| Zebrafish | 2 | 2018 | 3037 | 0.080 |
Why?
|
| Necrosis | 3 | 2018 | 1620 | 0.080 |
Why?
|
| Fossils | 1 | 2009 | 76 | 0.080 |
Why?
|
| Glioblastoma | 3 | 2015 | 3525 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2016 | 1245 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2018 | 2858 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2013 | 905 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1026 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1658 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2014 | 3408 | 0.080 |
Why?
|
| Cell Movement | 1 | 2020 | 5216 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2010 | 255 | 0.080 |
Why?
|
| Permeability | 2 | 2001 | 726 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 4978 | 0.080 |
Why?
|
| Pyridazines | 1 | 2010 | 203 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3629 | 0.080 |
Why?
|
| Xenopus laevis | 1 | 2012 | 966 | 0.080 |
Why?
|
| Time Factors | 6 | 2024 | 40261 | 0.080 |
Why?
|
| Alleles | 1 | 2019 | 6901 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7609 | 0.070 |
Why?
|
| Mice, Congenic | 2 | 2020 | 98 | 0.070 |
Why?
|
| Hematopoiesis | 2 | 2014 | 2059 | 0.070 |
Why?
|
| Lymphocytes | 1 | 2016 | 2614 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 1887 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 9618 | 0.070 |
Why?
|
| Jurkat Cells | 4 | 2011 | 739 | 0.070 |
Why?
|
| Risk | 1 | 2019 | 9621 | 0.070 |
Why?
|
| Prostatectomy | 1 | 2015 | 1841 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 458 | 0.070 |
Why?
|
| Mitosis | 2 | 2023 | 1181 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2016 | 3057 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2011 | 1099 | 0.070 |
Why?
|
| Transfection | 4 | 2016 | 5763 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 1248 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2019 | 5864 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1251 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 1966 | 0.070 |
Why?
|
| Base Sequence | 3 | 2013 | 12430 | 0.070 |
Why?
|
| Insulin | 3 | 2022 | 6610 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2021 | 2631 | 0.060 |
Why?
|
| Antigens, Differentiation | 2 | 2000 | 921 | 0.060 |
Why?
|
| Quinolines | 1 | 2011 | 772 | 0.060 |
Why?
|
| Skin | 1 | 2019 | 4506 | 0.060 |
Why?
|
| DNA | 2 | 2020 | 7214 | 0.060 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 13427 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2023 | 379 | 0.060 |
Why?
|
| Tyrosine | 1 | 2009 | 1427 | 0.060 |
Why?
|
| Enzyme Activation | 4 | 2021 | 3588 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 2009 | 0.060 |
Why?
|
| Molecular Structure | 3 | 2016 | 1885 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2018 | 1755 | 0.060 |
Why?
|
| Exercise | 1 | 2021 | 5954 | 0.060 |
Why?
|
| Anemia, Sideroblastic | 1 | 2025 | 112 | 0.060 |
Why?
|
| Purines | 2 | 2018 | 615 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2024 | 182 | 0.060 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 168 | 0.050 |
Why?
|
| Vitamin B 6 | 1 | 2025 | 237 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2023 | 185 | 0.050 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2023 | 85 | 0.050 |
Why?
|
| Lysine | 2 | 2023 | 1000 | 0.050 |
Why?
|
| Proteomics | 5 | 2020 | 3914 | 0.050 |
Why?
|
| Oxidative Stress | 3 | 2023 | 3139 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 2474 | 0.050 |
Why?
|
| Cytochromes c | 1 | 2003 | 173 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2023 | 317 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2010 | 12174 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2017 | 2179 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2024 | 453 | 0.050 |
Why?
|
| Femur | 1 | 2009 | 1321 | 0.050 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2022 | 21 | 0.050 |
Why?
|
| Quality of Life | 1 | 2024 | 13510 | 0.050 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2022 | 23 | 0.050 |
Why?
|
| Formates | 1 | 2022 | 37 | 0.050 |
Why?
|
| Carcinoma | 2 | 2012 | 2340 | 0.050 |
Why?
|
| Histones | 2 | 2023 | 2603 | 0.050 |
Why?
|
| Fermentation | 1 | 2002 | 143 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 997 | 0.050 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2022 | 72 | 0.050 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2022 | 77 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2021 | 11 | 0.050 |
Why?
|
| Mutagens | 1 | 2002 | 181 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 1739 | 0.050 |
Why?
|
| Methionine | 1 | 2023 | 573 | 0.050 |
Why?
|
| Ribosomes | 1 | 2024 | 499 | 0.050 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2022 | 338 | 0.050 |
Why?
|
| Immunoconjugates | 2 | 2000 | 976 | 0.050 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2020 | 14 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2025 | 391 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10765 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1752 | 0.040 |
Why?
|
| Electron Transport Complex III | 1 | 2020 | 31 | 0.040 |
Why?
|
| Methylation | 1 | 2023 | 1078 | 0.040 |
Why?
|
| Procollagen | 1 | 2021 | 189 | 0.040 |
Why?
|
| Protein Conformation | 3 | 2009 | 3956 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2003 | 4356 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2021 | 317 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2013 | 867 | 0.040 |
Why?
|
| Arginine | 2 | 2017 | 932 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2001 | 190 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2023 | 335 | 0.040 |
Why?
|
| Allosteric Site | 2 | 2012 | 105 | 0.040 |
Why?
|
| Molecular Typing | 1 | 2020 | 115 | 0.040 |
Why?
|
| DCMP Deaminase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2020 | 192 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 628 | 0.040 |
Why?
|
| Protein Binding | 4 | 2015 | 9344 | 0.040 |
Why?
|
| Growth Substances | 2 | 2000 | 760 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2023 | 664 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2010 | 1981 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2020 | 131 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 2238 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2812 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2021 | 202 | 0.040 |
Why?
|
| Neurons | 2 | 2023 | 9519 | 0.040 |
Why?
|
| CDC2 Protein Kinase | 1 | 2020 | 212 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11886 | 0.040 |
Why?
|
| Rhodamine 123 | 1 | 1999 | 37 | 0.040 |
Why?
|
| Gramicidin | 1 | 1999 | 12 | 0.040 |
Why?
|
| Cytokinesis | 1 | 2020 | 170 | 0.040 |
Why?
|
| Serotonin | 1 | 2024 | 1043 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2021 | 54962 | 0.040 |
Why?
|
| Diffusion | 1 | 2001 | 818 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3702 | 0.040 |
Why?
|
| Chromosomes | 1 | 2022 | 578 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 5801 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2025 | 980 | 0.040 |
Why?
|
| Nutritional Support | 1 | 2020 | 178 | 0.040 |
Why?
|
| Biology | 1 | 2021 | 292 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 329 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 323 | 0.040 |
Why?
|
| Hemin | 1 | 2018 | 51 | 0.040 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2018 | 32 | 0.040 |
Why?
|
| Single-Chain Antibodies | 1 | 2019 | 114 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5892 | 0.040 |
Why?
|
| Interphase | 1 | 1999 | 227 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 824 | 0.040 |
Why?
|
| Mitochondrial Swelling | 1 | 1997 | 15 | 0.040 |
Why?
|
| Antimycin A | 1 | 1997 | 31 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2000 | 684 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 1266 | 0.040 |
Why?
|
| Cisplatin | 2 | 2020 | 1661 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2023 | 1252 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 5804 | 0.040 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 1997 | 19 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 763 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 620 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 2018 | 149 | 0.040 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 1997 | 43 | 0.040 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2020 | 481 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 11116 | 0.040 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2017 | 81 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2017 | 101 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2024 | 1249 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2002 | 4413 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39394 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 835 | 0.030 |
Why?
|
| Heart Failure | 1 | 2021 | 11879 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2021 | 12806 | 0.030 |
Why?
|
| Jet Lag Syndrome | 1 | 2016 | 24 | 0.030 |
Why?
|
| Research Personnel | 1 | 2021 | 590 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 646 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2020 | 1762 | 0.030 |
Why?
|
| Gene Library | 1 | 2019 | 1062 | 0.030 |
Why?
|
| Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
| Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
| Kynurenic Acid | 1 | 2016 | 44 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16053 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 480 | 0.030 |
Why?
|
| Thymidine | 1 | 2016 | 297 | 0.030 |
Why?
|
| Parabiosis | 1 | 2016 | 65 | 0.030 |
Why?
|
| U937 Cells | 1 | 2016 | 260 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2021 | 840 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20776 | 0.030 |
Why?
|
| Period Circadian Proteins | 1 | 2016 | 97 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 524 | 0.030 |
Why?
|
| Acetylcysteine | 2 | 2011 | 262 | 0.030 |
Why?
|
| Plasma | 1 | 2019 | 585 | 0.030 |
Why?
|
| Temperature | 1 | 2002 | 2235 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2016 | 364 | 0.030 |
Why?
|
| Middle Aged | 10 | 2021 | 223737 | 0.030 |
Why?
|
| Brain | 2 | 2020 | 27453 | 0.030 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2015 | 15 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 796 | 0.030 |
Why?
|
| Acetone | 1 | 2015 | 44 | 0.030 |
Why?
|
| Aged | 9 | 2021 | 171786 | 0.030 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 1231 | 0.030 |
Why?
|
| Regeneration | 1 | 2024 | 1524 | 0.030 |
Why?
|
| Acyl Carrier Protein | 1 | 1994 | 24 | 0.030 |
Why?
|
| Pancreas | 1 | 2022 | 1700 | 0.030 |
Why?
|
| Perforin | 1 | 2015 | 167 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2017 | 569 | 0.030 |
Why?
|
| Genes, Plant | 1 | 1994 | 129 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 1026 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 2560 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6547 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2017 | 9684 | 0.030 |
Why?
|
| Microcephaly | 1 | 2018 | 426 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2015 | 458 | 0.030 |
Why?
|
| Prognosis | 3 | 2021 | 30046 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 706 | 0.030 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 1994 | 211 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 633 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2460 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1520 | 0.030 |
Why?
|
| Cause of Death | 1 | 2024 | 3721 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2015 | 395 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2014 | 354 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 2016 | 1895 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2000 | 2574 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3836 | 0.030 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2013 | 17 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1839 | 0.030 |
Why?
|
| Endocytosis | 1 | 1997 | 959 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65480 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 2487 | 0.030 |
Why?
|
| Genes, APC | 1 | 2013 | 146 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 347 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2016 | 484 | 0.030 |
Why?
|
| Plant Proteins | 1 | 1994 | 376 | 0.030 |
Why?
|
| RNA Interference | 2 | 2016 | 2835 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 2395 | 0.020 |
Why?
|
| Diamide | 1 | 2011 | 18 | 0.020 |
Why?
|
| Breast | 1 | 2021 | 1976 | 0.020 |
Why?
|
| Caspase 2 | 1 | 2011 | 26 | 0.020 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2011 | 37 | 0.020 |
Why?
|
| Glucagon | 1 | 2014 | 535 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6232 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2015 | 556 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 622 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2001 | 3659 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 669 | 0.020 |
Why?
|
| Body Height | 1 | 2017 | 1569 | 0.020 |
Why?
|
| Arabidopsis | 1 | 1994 | 469 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 587 | 0.020 |
Why?
|
| Palmitic Acid | 1 | 2011 | 149 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 1371 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 2820 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 367 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1124 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1999 | 1933 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1074 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2000 | 4528 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 716 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2010 | 55 | 0.020 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2010 | 22 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 23786 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3744 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22296 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 283 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2010 | 136 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2011 | 304 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 13048 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2960 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2002 | 437 | 0.020 |
Why?
|
| Bone Demineralization Technique | 1 | 2009 | 27 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2017 | 13055 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2010 | 333 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2122 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2013 | 910 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 1210 | 0.020 |
Why?
|
| Body Size | 1 | 2012 | 463 | 0.020 |
Why?
|
| Enzyme Assays | 1 | 2009 | 103 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2009 | 213 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 969 | 0.020 |
Why?
|
| B-Lymphocytes | 2 | 2003 | 4794 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 521 | 0.020 |
Why?
|
| Bone Matrix | 1 | 2009 | 127 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2010 | 213 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 1056 | 0.020 |
Why?
|
| Birds | 1 | 2009 | 166 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2009 | 260 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2630 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2000 | 282 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1997 | 2452 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 713 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2011 | 943 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1246 | 0.020 |
Why?
|
| K562 Cells | 1 | 2009 | 648 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1564 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 1833 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 2525 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1351 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1731 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6086 | 0.020 |
Why?
|
| Laminin | 1 | 2009 | 406 | 0.020 |
Why?
|
| Elastin | 1 | 2009 | 299 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 2916 | 0.020 |
Why?
|
| Osteocytes | 1 | 2009 | 193 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 699 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2019 | 3048 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8748 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2542 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 2414 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 945 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1742 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 2222 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4628 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10115 | 0.020 |
Why?
|
| Cysteine | 1 | 2011 | 897 | 0.020 |
Why?
|
| Hydrogen Peroxide | 2 | 2000 | 742 | 0.020 |
Why?
|
| Peptide Library | 1 | 2008 | 351 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1408 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 1647 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 59739 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 768 | 0.020 |
Why?
|
| Women's Health | 1 | 2016 | 2081 | 0.020 |
Why?
|
| Overweight | 1 | 2017 | 2448 | 0.020 |
Why?
|
| Nurses | 1 | 2016 | 2501 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2732 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2021 | 3463 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2018 | 3443 | 0.020 |
Why?
|
| Seizures | 1 | 2018 | 3000 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12873 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 1952 | 0.020 |
Why?
|
| Adult | 5 | 2021 | 223851 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3810 | 0.010 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2003 | 21 | 0.010 |
Why?
|
| Down-Regulation | 2 | 2002 | 2942 | 0.010 |
Why?
|
| Cytokines | 1 | 1999 | 7453 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6856 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2003 | 184 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2012 | 4148 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2012 | 2533 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2003 | 198 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14794 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2009 | 1531 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2635 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2024 | 24333 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2009 | 5151 | 0.010 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2002 | 16 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13318 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4076 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 3612 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8745 | 0.010 |
Why?
|
| Phylogeny | 1 | 2009 | 2843 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6023 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12562 | 0.010 |
Why?
|
| Ditiocarb | 1 | 2000 | 6 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 319 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3562 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 588 | 0.010 |
Why?
|
| Holoenzymes | 1 | 2000 | 39 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2000 | 67 | 0.010 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2000 | 59 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2000 | 46 | 0.010 |
Why?
|
| Etoposide | 1 | 2002 | 639 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2000 | 93 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11262 | 0.010 |
Why?
|
| Rotenone | 1 | 2000 | 50 | 0.010 |
Why?
|
| United States | 2 | 2021 | 73186 | 0.010 |
Why?
|
| Cobalt | 1 | 2000 | 148 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2000 | 235 | 0.010 |
Why?
|
| Oxidants | 1 | 2000 | 168 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6805 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2014 | 4432 | 0.010 |
Why?
|
| Electron Transport | 1 | 2000 | 211 | 0.010 |
Why?
|
| Hybridomas | 1 | 2000 | 444 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1997 | 7478 | 0.010 |
Why?
|
| Risk Factors | 2 | 2017 | 74976 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 375 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 9080 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 81903 | 0.010 |
Why?
|
| Cell Size | 1 | 2000 | 626 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2000 | 975 | 0.010 |
Why?
|
| Antigens, CD | 2 | 2000 | 4032 | 0.010 |
Why?
|
| Cyclins | 1 | 2000 | 606 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2000 | 595 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1997 | 72 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 9442 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 886 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2000 | 567 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2000 | 639 | 0.010 |
Why?
|
| Epilepsy | 1 | 2012 | 3326 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1505 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1997 | 303 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2000 | 878 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 36854 | 0.010 |
Why?
|
| G-Box Binding Factors | 1 | 1994 | 8 | 0.010 |
Why?
|
| Atrophy | 1 | 2000 | 1647 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 3626 | 0.010 |
Why?
|
| Plants, Toxic | 1 | 1994 | 70 | 0.010 |
Why?
|
| Plants, Genetically Modified | 1 | 1994 | 115 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1994 | 116 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5928 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 1994 | 153 | 0.010 |
Why?
|
| Ethanol | 1 | 2000 | 1331 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3775 | 0.010 |
Why?
|
| Ligands | 1 | 2000 | 3283 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18435 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 41808 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2000 | 2431 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1994 | 1524 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 2298 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1994 | 1498 | 0.010 |
Why?
|
| Reproduction | 1 | 1994 | 646 | 0.010 |
Why?
|
| Myocardium | 1 | 2000 | 4790 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1994 | 4124 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 60131 | 0.000 |
Why?
|